Literature DB >> 29566788

Tauomics and Kinetics in Human Neurons and Biological Fluids.

Henrik Zetterberg1.   

Abstract

In this issue of Neuron, Sato et al. (2018) combine proteomics and a stable isotope labeling method to examine different forms of tau and their kinetics in human neurons, brain, and cerebrospinal fluid and how these properties relate to clinical state and pathology in Alzheimer's disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29566788     DOI： 10.1016/j.neuron.2018.02.030

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  8 in total

1.  Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.

Authors:  Silke Kern; Jeremy A Syrjanen; Kaj Blennow; Henrik Zetterberg; Ingmar Skoog; Margda Waern; Clinton E Hagen; Argonde C van Harten; David S Knopman; Clifford R Jack; Ronald C Petersen; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2019-02-01       Impact factor: 18.302

2.  Differential effects of neurodegeneration biomarkers on subclinical cognitive decline.

Authors:  Andrew P Merluzzi; Nicholas M Vogt; Derek Norton; Erin Jonaitis; Lindsay R Clark; Cynthia M Carlsson; Sterling C Johnson; Sanjay Asthana; Kaj Blennow; Henrik Zetterberg; Barbara B Bendlin
Journal:  Alzheimers Dement (N Y)       Date:  2019-04-12

3.  Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.

Authors:  Antoine Leuzy; Claudia Cicognola; Konstantinos Chiotis; Laure Saint-Aubert; Laetitia Lemoine; Niels Andreasen; Henrik Zetterberg; Keqiang Ye; Kaj Blennow; Kina Höglund; Agneta Nordberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-04       Impact factor: 9.236

4.  Circulating Brain Injury Exosomal Proteins following Moderate-To-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications.

Authors:  Stefania Mondello; Vivian A Guedes; Chen Lai; Endre Czeiter; Krisztina Amrein; Firas Kobeissy; Yehia Mechref; Andreas Jeromin; Sara Mithani; Carina Martin; Chelsea L Wagner; Andras Czigler; Luca Tóth; Bálint Fazekas; Andras Buki; Jessica Gill
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

5.  N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.

Authors:  Anniina Snellman; Juan Lantero-Rodriguez; Andreja Emeršič; Agathe Vrillon; Thomas K Karikari; Nicholas J Ashton; Milica Gregorič Kramberger; Saša Čučnik; Claire Paquet; Uroš Rot; Henrik Zetterberg; Kaj Blennow
Journal:  Brain       Date:  2022-08-27       Impact factor: 15.255

6.  Sex Differences in Circulating T-Tau Trajectories After Sports-Concussion and Correlation With Outcome.

Authors:  Stefania Mondello; Vivian A Guedes; Chen Lai; Andreas Jeromin; Jeffrey J Bazarian; Jessica M Gill
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 7.  Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.

Authors:  Charles Arber; Argyro Alatza; Claire A Leckey; Ross W Paterson; Henrik Zetterberg; Selina Wray
Journal:  J Neurochem       Date:  2021-03-02       Impact factor: 5.372

Review 8.  Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.

Authors:  D O T Alawode; A J Heslegrave; N J Ashton; T K Karikari; J Simrén; L Montoliu-Gaya; J Pannee; A O Connor; P S J Weston; J Lantero-Rodriguez; A Keshavan; A Snellman; J Gobom; R W Paterson; J M Schott; K Blennow; N C Fox; H Zetterberg
Journal:  J Intern Med       Date:  2021-06-26       Impact factor: 8.989
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.